MedPath
NMPA Approval

Levetiracetam Sustained-release Tablets

国药准字H20243195

February 20, 2024

Drug Information

左乙拉西坦缓释片

片剂

0.5g

化学药品

February 20, 2024

Company Information

Applicant Company

北京市朝阳区百子湾西里402号楼21层2111

Manufacturing Company

北京市通州区中关村科技园光机电基地经海七路3号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

左乙拉西坦缓释片 - NMPA 批准文号 | MedPath